Investors eyeing a purchase of Akebia Therapeutics Inc (AKBA) stock, but cautious about paying the going market price of $2.50/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April 2022 put at the $2 strike, which has a bid at the time of this writing of 35 cents..